Academic journals in blood cancer aims to publish most complete and reliable source of information on the discoveries and current developments in the form of original articles, review articles, case reports, short communications, etc. related to Cancer research and therapy and making them freely available through online without any restrictions or any other subscriptions to researchers worldwide.
Leukemia is the most prevalent cancer in children. As an increasing number of cancer survivors reaches adulthood, there may be consequences of the treatment, and there is an issue if low bone mass might be included as a significant late effect. Acute lymphocytic leukemia patients may have their bone mass compromised during therapy and many years after its withdrawal, but the degree of bone mass decline or recovery are not well elucidated to date. Our target is to make a warning about the difficulties in assessing and interpreting bone mass in children and adolescents, the limitations in this assessment in acute lymphocytic leukemia young survivors, the possibility of misdiagnoses, as well as the reasons (if there are any) of low bone mass in this particular group of cancer survivors.
Last date updated on November, 2020